デラウェア州における乳がんの臨床試験
デラウェア州内の拠点で、乳がんに関する9件の研究が参加者を募集しています。
デラウェア州内の都市
公式研究テキスト（英語）
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Medical Oncology Hematology Consultants, Newark
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- Medical Oncology Hematology Consultants (MOHC) ( Site 8002), Newark
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07060807Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- Medical Oncology Hematology Consultants, P.A., Newark
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06982521Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Bayhealth Hospital Kent Campus, Dover
- Beebe Medical Center, Lewes
- Bayhealth Hospital Sussex Campus, Milford
- 他6件
被験者募集中第3相
18歳〜60歳 · 女性 · 2026/09/02更新 · NCT05879926A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
- Medical Oncology Hematology Consultants, PA, Newark
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/08/10更新 · NCT06926868Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Beebe South Coastal Health Campus, Millville
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
- 他1件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Newark
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Bayhealth Hospital Kent Campus, Dover
- Beebe South Coastal Health Campus, Frankford
- Beebe Health Campus, Rehoboth Beach
被験者募集中第3相
18歳以上 · 全性別 · 2025/10/08更新 · NCT03418961MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
- Medical Oncology and Hematology Consultants, Newark
被験者募集中観察研究
18歳以上 · 全性別 · 2025/08/20更新 · NCT03053193ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。